· Insider activity · ABBV
AbbVie Inc (ABBV) director acquisition adds insider angle to a strong tape
The disclosure gives investors a governance marker as the drugmaker trades with heavier turnover and firm relative performance.
AbbVie Inc (ABBV) disclosed insider activity dated May 8, with director Jennifer L. Davis acquiring 1,118 shares of common stock at a reported transaction price of $0.00. The stock last closed at $253.35.
Weekly market data show a 17.0% one-week return and a 16.4% four-week return, with latest volume at 2.61 times the 13-week average. Market Dynamics is positive confirmation at 0.79 and Relative Strength is 9.3, though the trend signal remains inactive.